摘要
目的对比两种不同手术在风湿性二尖瓣心脏病患者治疗中的临床效果。方法选取2019-5~2020-1于我院接受治疗的126例风湿性二尖瓣心脏病患者,根据手术方法不同分为观察组(n=63)、对照组(n=63)。对照组实施二尖瓣置换术(MVR)治疗,观察组实施二尖瓣成形术(MVP)治疗。记录两组手术时间、体外循环时间、术中出血量、呼吸机辅助时间及住院天数,对比治疗前后心功能[左心房内径(LAD)、左心室收缩末期内径(LVEDD)、左心室舒张末期容积(LVEDV)、左心室射血分数(LVEF)]及并发症发生情况。结果观察组手术时间、体外循环时间高于对照组,术中出血量、呼吸机辅助时间及住院天数均低于对照组,差异有统计学意义(P<0.05);术后两组LAD、LVEDD、LVEDV较术前降低,LVEF较术前升高,且观察组LAD、LVEDD、LVEDV低于对照组,LVEF高于对照组,差异有统计学意义(P<0.05);观察组并发症发生率6.35%(4/63)低于对照组19.05%(12/63),差异有统计学意义(P<0.05)。结论同MVR术相比,采用MVP术治疗风湿性二尖瓣心脏病能降低术中出血量,改善患者心功能,促进病情恢复,减少术后呼吸机辅助及缩短住院时间,且能降低并发症发生风险。
Objective To compare the clinical effects of two different surgeries in the treatment of patients with rheumatic mitral valve heart disease.Methods A total of 126 patients with rheumatic mitral valve heart disease who were treated in our hospital from May 2019 to January 2020 were selected and divided into observation group(n=63)and control group(n=63)according to different surgical methods.The control group was treated with mitral valve replacement(MVR),and the observation group was treated with mitral valvuloplasty(MVP).The operation time,cardiopulmonary bypass time,intraoperative blood loss,ventilator assistance time,and hospitalization days were recorded in the two groups,and the cardiac function[left atrial diameter(LAD),left ventricular end-systolic diameter(LVEDD),left ventricular end-diastolic volume]before and after treatment were compared.(LVEDV),left ventricular ejection fraction(LVEF)J and complications.Results The operation time and cardiopulmonary bypass time of the observation group were higher than those of the control group,and the intraoperative blood loss,ventilator assistance time and hospitalization days were all lower than those of the control group,and the differences were statistically significant(P<0.05).LAD,LVEDD and LVEDV in the observation group were lower than those before operation,and LVEF was higher than those before operation.The LAD,LVEDD and LVEDV in the observation group were lower than those in the control group,and the LVEF in the observation group was higher than that in the control group,and the differences were statistically significant(P<0.05).6.35%(4/63)was lower than 19.05%(12/63)of the control group,and the difference was statistically significant(P<0.05).Conclusion Compared with MVR,the use of MvP in the treatment of rheumatic mitral heart disease can reduce intraoperative blood loss,improve cardiac function,promote recovery,reduce postoperative ventilator assistance,shorten hospital stay,and reduce complications.Risk occurs.
作者
韩冰
朱海文
冯世军
Han Bing;Zhu Haiwen;Feng Shijun(Zhumadian Central Hospital Zhumadian,Henan 463000)
出处
《辽宁医学杂志》
2023年第4期19-22,共4页
Medical Journal of Liaoning
关键词
二尖瓣成形术
二尖瓣置换术
风湿性二尖瓣心脏病
心功能
Mitral Valvuloplasty
Mitral Valve Replacement
Rheumatic Mitral Heart Disease
Heart Function
